Learn more at LeadIQ.com

Insights

Cutting-edge mRNA technology CureVac is a leading biotech company specializing in mRNA technology for developing vaccines and therapeutic proteins. The advancement of mRNA technology for medical applications presents a significant sales opportunity for CureVac, as the demand for innovative solutions in healthcare continues to grow.

Collaborations with major pharmaceutical companies CureVac has established partnerships with global pharmaceutical giants like GSK, signaling credibility and potential sales expansion opportunities. Leveraging these collaborations, CureVac can tap into larger markets, access new distribution channels, and enhance its product reach to drive sales growth.

Promising pipeline and product portfolio With a diverse pipeline encompassing cancer vaccines, prophylactic vaccines, and therapeutic proteins, CureVac's robust product portfolio holds significant potential for generating sales. The promising Phase 2 data for a seasonal flu shot and the ongoing development of mRNA-based vaccines further position the company for sales success in the biotech sector.

Recent key hires and strategic appointments CureVac's strategic appointments, such as hiring a new Chief Business Officer and adding an independent director to the Supervisory Board, demonstrate a commitment to strengthening leadership and expertise. These key personnel additions not only enhance CureVac's industry positioning but also open doors for potential sales collaborations and partnerships.

Cost optimization and workforce restructuring The recent reduction in headcount by 150 employees as part of a cost optimization strategy presents an opportunity for CureVac to streamline operations and drive efficiency. This strategic move can lead to a leaner organizational structure, potentially increasing productivity and enabling the company to allocate resources more effectively to boost sales performance.

Similar companies to CureVac

CureVac Tech Stack

CureVac uses 8 technology products and services including Atlassian, NetApp, SAP HANA, and more. Explore CureVac's tech stack below.

Atlassian
Application Development & Management
NetApp
Data Management
SAP HANA
Database Management
SAP ERP
Enterprise Resource Planning
Google Font API
Font Scripts
Microsoft
Miscellaneous
JSON
Programming Languages
Apache
Web Servers

Media & News

CureVac's Email Address Formats

CureVac uses at least 1 format(s):

CureVac Email Formats	Example	Percentage
First.Last@curevac.com	John.Doe@curevac.com	98%
First.MiddleLast@curevac.com	John.MichaelDoe@curevac.com	1%
LF@curevac.com	DJ@curevac.com	1%

Frequently Asked Questions

Where is CureVac's headquarters located?

CureVac's main headquarters is located at Friedrich-Miescher-Str. 15 Tübingen, Baden-Württemberg 72076 DE. The company has employees across 6 continents, including EuropeNorth AmericaSouth America.

What is CureVac's phone number?

You can contact CureVac's main corporate office by phone at

+49-7071-9****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CureVac's stock symbol?

CureVac is a publicly traded company; the company's stock symbol is CVAC.

What is CureVac's official website and social media links?

CureVac's official website is curevac.com and has social profiles on LinkedIn.

How much revenue does CureVac generate?

As of September 2024, CureVac's annual revenue reached $750M.

What is CureVac's SIC code NAICS code?

CureVac's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CureVac have currently?

As of September 2024, CureVac has approximately 1K employees across 6 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Executive Officer: A. Z.Chief Business Officer: T. R.Chief Operating Officer: M. G.. Explore CureVac's employee directory with LeadIQ.

What industry does CureVac belong to?

CureVac operates in the Biotechnology Research industry.

What technology does CureVac use?

CureVac's tech stack includes AtlassianNetAppSAP HANASAP ERPGoogle Font APIMicrosoftJSONApache.

What is CureVac's email format?

CureVac's email format typically follows the pattern of . Find more CureVac email formats with LeadIQ.

How much funding has CureVac raised to date?

As of September 2024, CureVac has raised $250M in funding. The last funding round occurred on Feb 07, 2023 for $250M.

When was CureVac founded?

CureVac was founded in 2000.

CureVac

CureVac

Biotechnology ResearchBaden-Württemberg, Germany1001-5000 Employees

CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In more than two decades of developing, optimizing, and manufacturing this versatile biological molecule for medical purposes, CureVac has introduced and refined key underlying technologies that were essential to the production of mRNA vaccines against COVID-19, and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is leveraging mRNA technology, combined with advanced omics and computational tools, to design and develop off-the-shelf and personalized cancer vaccine product candidates. It also develops programs in prophylactic vaccines and in treatments that enable the human body to produce its own therapeutic proteins. Headquartered in Tübingen, Germany, CureVac also operates sites in the Netherlands, Belgium, Switzerland, and the U.S. Further information can be found at www.curevac.com.

Company Overview

Headquarters: Friedrich-Miescher-Str. 15 Tübingen, Baden-Württemberg 72076 DE
Phone number: ✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+49-7071-9****
Website: curevac.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: CVAC
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2000
Employees: 1001-5000

Media & News

Funding & Financials

$250M
CureVac has raised a total of $250M of funding over 14 rounds. Their latest funding round was raised on Feb 07, 2023 in the amount of $250M.
$100M$1B
CureVac's revenue is in the range of $100M$1B

Funding & Financials

$250M
CureVac has raised a total of $250M of funding over 14 rounds. Their latest funding round was raised on Feb 07, 2023 in the amount of $250M.
$100M$1B
CureVac's revenue is in the range of $100M$1B

Company Leadership

A. Z.
Chief Executive Officer
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. R.
Chief Business Officer
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. G.
Chief Operating Officer
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. F.
Chief Technology Officer
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. V. D. M.
Chief Production Officer
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

M. F.
Chief Technology Officer
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. O.
Office Manager & Executive Assistant To Cdo/Cmo | Clinical Operations Associate
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. V. D. M.
Chief Production Officer
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. S.
Executive Assistant To Cdo
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. D.
Solution Owner - Mrna Design Tools
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CureVac and Millions of Other Companies
Sign up for full access to CureVac information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.